TRIM14 and lung adenocarcinoma: TCGA data reveals rare mutations (0.6–2.9%) and deletions (1%) in either lung adenocarcinoma or squamous carcinoma, suggesting that TRIM14 loss of function in NSCLC may be attributed to epigenetic regulation (http://www.cbioportal.org/).